Literature DB >> 9848903

Prolonged urticaria with 17-1A antibody.

N Sizmann1, H C Korting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9848903      PMCID： PMC28742          DOI： 10.1136/bmj.317.7173.1631

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A.

Authors:  J Fagerberg; P Ragnhammar; M Liljefors; A L Hjelm; H Mellstedt; J E Frödin
Journal:  Cancer Immunol Immunother       Date:  1996-02       Impact factor: 6.968

2.  Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.

Authors:  A F LoBuglio; R H Wheeler; J Trang; A Haynes; K Rogers; E B Harvey; L Sun; J Ghrayeb; M B Khazaeli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 3.  An overview of adjuvant therapy for colorectal cancer.

Authors:  D G Haller
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

4.  Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.

Authors:  J Fagerberg; M Steinitz; H Wigzell; P Askelöf; H Mellstedt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

Authors:  G Riethmüller; E Schneider-Gädicke; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; H Pichlmaier; H Hirche; R Pichlmayr
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321
  5 in total
  1 in total

1.  Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy.

Authors:  Seyed-Ali Hosseinian; Aliakbar Haddad-Mashadrizeh; Samaneh Dolatabadi
Journal:  Adv Pharm Bull       Date:  2018-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.